GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (NAS:RCEL) » Definitions » Cyclically Adjusted PB Ratio

AVITA Medical (AVITA Medical) Cyclically Adjusted PB Ratio : 4.53 (As of Jun. 01, 2024)


View and export this data going back to 2012. Start your Free Trial

What is AVITA Medical Cyclically Adjusted PB Ratio?

As of today (2024-06-01), AVITA Medical's current share price is $9.61. AVITA Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $2.12. AVITA Medical's Cyclically Adjusted PB Ratio for today is 4.53.

The historical rank and industry rank for AVITA Medical's Cyclically Adjusted PB Ratio or its related term are showing as below:

RCEL' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.59   Med: 8.38   Max: 115.43
Current: 4.4

During the past years, AVITA Medical's highest Cyclically Adjusted PB Ratio was 115.43. The lowest was 2.59. And the median was 8.38.

RCEL's Cyclically Adjusted PB Ratio is ranked worse than
74.95% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 2.07 vs RCEL: 4.40

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AVITA Medical's adjusted book value per share data for the three months ended in Mar. 2024 was $1.263. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.12 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AVITA Medical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for AVITA Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical Cyclically Adjusted PB Ratio Chart

AVITA Medical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.66 50.89 17.51 3.57 6.50

AVITA Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.25 8.39 7.09 6.50 7.58

Competitive Comparison of AVITA Medical's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, AVITA Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVITA Medical's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AVITA Medical's Cyclically Adjusted PB Ratio falls into.



AVITA Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

AVITA Medical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=9.61/2.12
=4.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AVITA Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, AVITA Medical's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.263/131.7762*131.7762
=1.263

Current CPI (Mar. 2024) = 131.7762.

AVITA Medical Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.282 100.560 0.370
201409 0.000 100.428 0.000
201412 0.098 99.070 0.130
201503 0.000 99.621 0.000
201506 0.134 100.684 0.175
201509 0.000 100.392 0.000
201512 0.209 99.792 0.276
201603 0.000 100.470 0.000
201606 0.171 101.688 0.222
201609 0.000 101.861 0.000
201612 0.207 101.863 0.268
201703 0.000 102.862 0.000
201706 0.111 103.349 0.142
201709 0.000 104.136 0.000
201712 0.215 104.011 0.272
201803 0.000 105.290 0.000
201806 0.219 106.317 0.271
201809 0.000 106.507 0.000
201812 0.266 105.998 0.331
201903 0.000 107.251 0.000
201906 0.223 108.070 0.272
201909 0.000 108.329 0.000
201912 0.205 108.420 0.249
202003 0.000 108.902 0.000
202006 3.373 108.767 4.087
202009 3.029 109.815 3.635
202012 2.756 109.897 3.305
202103 4.788 111.754 5.646
202106 4.646 114.631 5.341
202109 4.473 115.734 5.093
202112 0.000 117.630 0.000
202203 3.920 121.301 4.259
202206 3.702 125.017 3.902
202209 3.515 125.227 3.699
202212 3.362 125.222 3.538
202303 3.062 127.348 3.168
202306 2.698 128.729 2.762
202309 2.465 129.860 2.501
202312 1.910 129.419 1.945
202403 1.263 131.776 1.263

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AVITA Medical  (NAS:RCEL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


AVITA Medical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of AVITA Medical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AVITA Medical (AVITA Medical) Business Description

Address
28159 Avenue Stanford, Suite 220, Valencia, Los Angeles, CA, USA, 91355
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.
Executives
James Corbett director 2 GOODYEAR, IRVINE CA 92618
Jeremy Curnock Cook director TARGETED GENETICS CORP, 1100 OLIVE WAY STE 100, SEATTLE WA 98101
David D O'toole officer: CFO 1640 MARENGO STREET, LOS ANGELES CA 90033
Donna Shiroma officer: General Counsel C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
Cary Guy Vance director 800 EAST MIDDLEFIELD RD, MOUNTAIN VIEW CA 94043
Robert Mcnamara director C/O LDR HOLDING CORPORATION, 13785 RESEARCH BOULEVARD, SUITE 200, AUSTIN TX 78750
Michael S Perry director, officer: Chief Executive Officer C/O BIOTRANSPLANT INC, 196 BOSTON AVE SUITE 2800, MEDFORD MA 02155
Suzanne Crowe director C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
Jan Stern Reed director C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
Michael Holder officer: Chief Financial Officer 6170 RESEARCH RD., STE 103, FRISCO TX 75034
Kathy M. Mcgee officer: Chief Operating Officer C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
Sean Ekins officer: Sr. VP of Finance C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355
David Mcintyre officer: Chief Financial Officer SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Damien Mcdonald director 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY
Erin Liberto officer: Chief Commercial Officer C/O AVITA MEDICAL, 28159 AVENUE STANFORD, SUITE 220, VALENCIA CA 91355